Editas (EDIT) CSO Linda Burkly Sells 4,928 Shares

What Happened
Linda Burkly, Executive Vice President and Chief Scientific Officer of Editas Medicine (EDIT), sold 4,928 shares on 2026-07-28 at $2.67 per share, generating proceeds of $13,158. The transaction is reported as a sale (S) and was executed to satisfy tax withholding obligations tied to recent restricted stock unit (RSU) vesting.

Key Details

• Transaction date and price: 2026-07-28, 4,928 shares at $2.67/share, total ~$13,158.
• Transaction type: Sale (reported as "Open market or private sale" in the filing).
• Footnote: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the reporting person on July 3, 2023; it represents the sale of shares necessary to meet tax withholding for RSUs that vested on July 24, 2026, and was not a discretionary trade by the insider.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Form 4 filed 2026-07-29 for a 2026-07-28 transaction — no late filing indicated.

Context: This was a routine, non-discretionary sale to cover tax withholding from RSU vesting rather than an independent investment decision. Such withholding sales are common and do not by themselves signal insider sentiment about the company’s outlook.